Screener
USANA Health Sciences USNA Hiya — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Core Nutritional | Hiya | Rise | Total |
|---|---|---|---|---|
| Cost of sales | 36,749 | 9,983 | 12,704 | 59,436 |
| Brand Partner incentives | 88,654 | — | — | 88,654 |
| Selling, general and administrative (2) | 60,747 | 24,771 | 2,736 | 88,254 |
| Segment earnings (loss) from operations | $18,249 | $(2,604) | $(1,771) | $13,874 |
| Reconciliation of segment earnings from operations | ||||
| Interest income | 437 | |||
| Interest expense | (240) | |||
| Other, net | 1,394 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's hiya — operating income (loss)?
- USANA Health Sciences (USNA) reported hiya — operating income (loss) of -$2.6M in Q1 2026.
- How has USANA Health Sciences's hiya — operating income (loss) changed year-over-year?
- USANA Health Sciences's hiya — operating income (loss) decreased by 390.4% year-over-year, from -$531K to -$2.6M.
- What does hiya — operating income (loss) mean?
- Measures the profitability of the Hiya segment by subtracting cost of sales, brand partner incentives, and operating expenses from net sales. This figure indicates the segment's ability to generate profit from its core business operations before interest and taxes. It is a vital indicator of the segment's financial health and its contribution to the company's total operating performance.
Ask your AI about USANA Health Sciences's hiya — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude